Strategic posture: Airbus is positioned as the industry leader in narrow‑body aircraft, focused on consolidating its commercial‑airliner franchise while slimming noncore defense businesses to improve profitability and program discipline.

Market advantage: The A320neo family (especially the A321neo) is the company’s primary growth engine and competitive moat; Boeing’s uneven recovery has given Airbus a multi‑year window to strengthen share in single‑aisle markets.

Production constraints: Engine shortages, supplier fragility, and labor constraints are the binding constraints on converting backlog into revenue; these bottlenecks have pushed planned A320 monthly‑rate targets out to 2027.

Delivery and backlog trajectory: Airbus delivered 793 aircraft in 2025 (up from 766 in 2024) and is targeting 870 deliveries in 2026, but the ability to meet that target depends on resolving supply‑chain and engine issues.

Key financials — company level: 2025 revenue €73.4bn (+6%), EBIT €6.1bn, EBIT margin 8% (unchanged from 2024); management still targets a 10% operating margin but has repeatedly fallen short.

Key financials — balance sheet & leverage: Long‑term debt fell to €9.1bn by end‑2025 (from a pandemic peak), improving leverage but leaving sensitivity to program charges and working‑capital swings.

Segment performance: Commercial Transport: €51.6bn (70% of group) and 793 deliveries; segment EBIT €4.555bn (down 11% YoY). Helicopters: €8.62bn (+13%), EBIT €953m (+17%). Defence & Space: €13.34bn (+11%), EBIT €639m (turned from a loss in 2024).

One‑offs and adjusted results: Airbus routinely reports large EBIT adjustments (penalties, program charges, disposals); adjustments exceeded €1bn in 2025, which complicates interpretation of “adjusted” profitability.

Program and product outlook: Widebody demand supports the A350 and A330neo franchises (A350 efficiency cited), with A350 production targets rising toward 10/month in 2026 and 12/month by 2028; A220 and A330 ramp targets are more uncertain.